Yves Chrétien

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

Christophe Corpechot, Ludovico Abenavoli, Nabila Rabahi et al. · Hepatology · 2008 · 651 citations

Medicine, Biochemistry, Pharmacology +10

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis

Gabriel Perlemuter, Abdelmajid Sabile, Philippe Lettéron et al. · The FASEB Journal · 2002 · 574 citations

Life Sciences, Biochemistry, Infectious Diseases +17

IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?

Raoul Poupon, RenéeE. Poupon, Yvon Calmus et al. · The Lancet · 1987 · 539 citations

Medicine, Internal Medicine, Pharmacology +9

The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis

Christophe Corpechot, Fabrice Carrat, Abbas Bahr et al. · Gastroenterology · 2005 · 390 citations

Medicine, Internal Medicine, Pharmacology +10

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.

M. Housset, C Maulard, Yves Chrétien et al. · Journal of Clinical Oncology · 1993 · 317 citations

Medicine, Oncology, Surgery +17